In a meeting with industry, the Dutch Ministry of Health, Welfare and Sport (WVS) confirmed its intent to ban the botanical ashwagandha, a widely used dietary supplement and functional food/beverage ingredient.
SuppCo’s mobile application evaluates dietary supplements using its TrustScore methodology. Eurofins Supplement Testing and the Eurofins Assurance provide testing services and certification programs for dietary supplements and ingredients.
Although FDA was unable to find a cause of contamination, a single supplier of the contaminated moringa powder was identified. Affected products, which were sold under the Rosabella brand and distributed by Ambrosia Brands LLC, have been recalled.
The products have been recalled, but have a long shelf life. FDA previously reported working with the manufacturers to determine the root cause of contamination, but has not shared an update at the time of the investigation’s close.
Recent contamination incidents involving moringa products draw attention to supply chain vulnerabilities that affect many botanical ingredients used in the global natural health industry. These events offer an opportunity to examine where problems can emerge and how companies can better protect consumer safety.
The March 27 hybrid event will discuss new methodologies to produce existing dietary ingredients and specific ingredient types, including proteins, enzymes, and microbials, within the scope of the Dietary Supplement Health and Education Act of 1994.
The moringa powder capsules are sold under the Rosabella brand name and are distributed by Ambrosia Brands LLC. The outbreak strain is resistant to all first-line and alternative antibiotics commonly recommended for salmonellosis treatment.
Citing reports of contamination and a lack of federal oversight, California Senator Steve Padilla introduced SB 1033, which would require manufacturers of protein products to test their products for heavy metals and publicly disclose their findings.
EFSA established a provisional safe intake level for adults for CBD as a novel food while highlighting that data gaps continue to exist regarding possible effects of CBD on the liver and the endocrine, nervous, and reproductive systems.
The global trend toward natural and functional foods has fueled the popularity of edible flowers. To investigate the associated food safety risks, researchers conducted a comprehensive literature review, and identified pyrrolizidine and tropane alkaloids as a significant concern.
